India to Kazakhstan: Ornidazole Export Trade Route

The India to Kazakhstan Ornidazole corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $69.3K USD. The route is dominated by KUSUM HEALTHCARE PVT LTD, which alone accounts for roughly 45% of all export value, reflecting the consolidated nature of India's ornidazole manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $11.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with ornidazole's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 30.6%, placing it at rank #9 among India's top ornidazole export destinations globally.

On the import side, key buyers of Indian ornidazole in Kazakhstan include LLP DARI-PHARM KAZAKHSTAN BUILDING, LLP "DARI-PHARM (KAZAKHSTAN), RM PHARM LTD. LLP DARI-PHARM KAZAKHSTAN BUILDING is the single largest importer with 1 shipments valued at $30.9K USD.

India's ornidazole exports to Kazakhstan are driven primarily by a handful of large-scale manufacturers. KUSUM HEALTHCARE PVT LTD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Kazakhstan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — KUSUM HEALTHCARE PVT LTD, KUSUM HEALTHCARE PRIVATE LIMITED, INTER PHARMA — together account for 100% of total trade value on this route. The average shipment value of $11.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as orgyl tablets 1x10s (ornidazole 500 mgtablets) batch no. 1005234 dom - 10.2024doe - 09.2028 and pharmaceutical product- ozole (ornidazole infusion 5mg/ml)b.no.216950130,mfg:03/2025,exp:02/2027 (as per inv), suggesting that buyers in Kazakhstan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LLP DARI-PHARM KAZAKHSTAN BUILDING is the largest importer with 1 shipments worth $30.9K USD — representing 45% of all ornidazole imports from India on this route.